Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl-
AT77608
CAS 138801-72-6
1000 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $141.10 | Total: $705.50 |
| 1 | 10 | $119.52 | Total: $1,195.20 |
| 1 | 25 | $101.26 | Total: $2,531.50 |
| 1 | 50 | $86.32 | Total: $4,316.00 |
| 1 | 100 | $74.70 | Total: $7,470.00 |
Overview
1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- can be used as a broad-spectrum antimicrobial agent with inhibitory activity against Aspergillus niger Bacillus subtilis, Pseudomonas albicans, Escherichia coli and Staphylococcus aureus.1H-Indole, 3,3'-(2-thienylmethylene) bis[2-methyl- showed anti-inflammatory activity in in vitro experiments and can be used to treat bacterial infections.
Chemical Properties
| Molecular Formula | C23H20N2S |
| Molecular Weight | 356.48 |
| CAS Numbers | 138801-72-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC1=C(C(C2=CC=CS2)C2=C(C)NC3=C2C=CC=C3)C2=C(N1)C=CC=C2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Nagre D T, et al. Synthesis, in-silico potential enzymatic target predictions, pharmacokinetics, toxicity, anti-microbial and anti-inflammatory studies of bis-[2-methylindolyl] methane derivatives. Current Enzyme Inhibition. 2021; 17[2] 127-143.